After Arcellx buyout close, Gilead trims 108 jobs at CAR-T biotech's Redwood City outpost
With Gilead's $7.8 billion buyout of Arcellx complete, the California pharma is consolidating some of the workforce at the acquired company.
With Gilead's $7.8 billion buyout of Arcellx complete, the California pharma is consolidating some of the workforce at the acquired company.